{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T06:16:39Z","timestamp":1789193799630,"version":"build-2803163510"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T00:00:00Z","timestamp":1631664000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T00:00:00Z","timestamp":1631664000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"autonomous non-profit organization \u201csociety of specialists in the field of innovative technologies in medicine\u201d"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s10557-021-07235-6","type":"journal-article","created":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T01:02:58Z","timestamp":1631667778000},"page":"1147-1155","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Influence of Moxonidine and Bisoprolol on Morphofunctional Condition of Arterial Wall and Telomerase Activity in Postmenopausal Women with Arterial Hypertension and Osteopenia. The Results from a Moscow Randomized Study"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7891-6850","authenticated-orcid":false,"given":"E.","family":"Dudinskaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4193-688X","authenticated-orcid":false,"given":"O.","family":"Tkacheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5405-5459","authenticated-orcid":false,"given":"E.","family":"Bazaeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2028-3939","authenticated-orcid":false,"given":"L.","family":"Matchekhina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0048-268X","authenticated-orcid":false,"given":"K.","family":"Eruslanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6465-4842","authenticated-orcid":false,"given":"N.","family":"Sharashkina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1628-5093","authenticated-orcid":false,"given":"Yu.","family":"Kotovskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7825-5597","authenticated-orcid":false,"given":"V.","family":"Larina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,15]]},"reference":[{"key":"7235_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1385\/ENDO:23:1:01","volume":"23","author":"SI McFarlane","year":"2004","unstructured":"McFarlane SI, Muniyappa R, Shin JJ, Bahtiyar G, Sowers JR. Osteoporosis and cardiovascular disease. Endocrine. 2004;23:1\u201310.","journal-title":"Endocrine"},{"key":"7235_CR2","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/0140-6736(91)90489-C","volume":"338","author":"WS Browner","year":"1991","unstructured":"Browner WS, Seeley DG, Cummings SR, Vogt TM, Group FTSOOFR. Non-trauma mortality in elderly women with low bone mineral density. Lancet Elsevier. 1991;338:355\u20138.","journal-title":"Lancet Elsevier"},{"key":"7235_CR3","first-page":"940","volume":"24","author":"WS Browner","year":"1993","unstructured":"Browner WS, Pressman AR, Nevitt MC, Cauley JA, Cummings SR. Association between low bone density and stroke in elderly women. The study of osteoporotic fractures. Stroke. Am Heart Assoc. 1993;24:940\u20136.","journal-title":"Am Heart Assoc"},{"key":"7235_CR4","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0140-6736(99)01437-3","volume":"354","author":"FP Cappuccio","year":"1999","unstructured":"Cappuccio FP, Meilahn E, Zmuda JM, Cauley JA. High blood pressure and bone-mineral loss in elderly white women: a prospective study. Lancet. Elsevier. 1999;354:971\u20135.","journal-title":"Lancet. Elsevier"},{"key":"7235_CR5","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s00198-011-1631-0","volume":"23","author":"P Wiklund","year":"2012","unstructured":"Wiklund P, Nordstr\u00f6m A, Jansson J-H, Weinehall L, Nordstr\u00f6m P. Low bone mineral density is associated with increased risk for myocardial infarction in men and women. Osteoporos Int. 2012;23:963\u201370.","journal-title":"Osteoporos Int"},{"key":"7235_CR6","first-page":"19","volume":"5","author":"GN Farhat","year":"2008","unstructured":"Farhat GN, Cauley JA. The link between osteoporosis and cardiovascular disease. Clin cases miner bone Metab. CIC Edizioni Int. 2008;5:19\u201334.","journal-title":"CIC Edizioni Int"},{"key":"7235_CR7","doi-asserted-by":"crossref","unstructured":"Strazhesko ID, Akasheva DU, Dudinskaya EN, Tkacheva ON. Vascular ageing: main features and mechanisms. Cardiovasc Ther Prev. 2012;11(4).","DOI":"10.15829\/1728-8800-2012-4-93-100"},{"key":"7235_CR8","doi-asserted-by":"crossref","unstructured":"Nilsson PM, Boutouyrie P, Cunha P, Kotsis V, Narkiewicz K, Parati G, et al. Early vascular ageing in translation: from laboratory investigations to clinical applications in cardiovascular prevention. J Hypertens. 2013;31:1517\u201326.","DOI":"10.1097\/HJH.0b013e328361e4bd"},{"key":"7235_CR9","first-page":"1626","volume":"19","author":"P Fragkiadaki","year":"2020","unstructured":"Fragkiadaki P, et al. Telomere length and telomerase activity in osteoporosis and osteoarthritis (review). Exp Ther Med. 2020;19:1626\u201332.","journal-title":"Exp Ther Med"},{"key":"7235_CR10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/35040500","volume":"408","author":"EH Blackburn","year":"2000","unstructured":"Blackburn EH. Telomere states and cell fates. Nature. 2000;408:53\u20136.","journal-title":"Nature"},{"key":"7235_CR11","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/nm1006-1133","volume":"12","author":"EH Blackburn","year":"2006","unstructured":"Blackburn EH, Greider CW, Szostak JW. Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging. Nat Med. 2006;12:1133\u20138.","journal-title":"Nat Med"},{"key":"7235_CR12","doi-asserted-by":"crossref","unstructured":"Strojek K, Grzeszczak W, Gorska J, Leschinger MI, Ritz E. Lowering of microalbuminuria in diabetic patients by a sympathicoplegic agent: novel approach to prevent progression of diabetic nephropathy? J Am Soc Nephrol. 2001; 12:602 LP\u2013605.","DOI":"10.1681\/ASN.V123602"},{"key":"7235_CR13","doi-asserted-by":"crossref","unstructured":"Krespi P, et al. Moxonidine effect on microalbuminuria, trombomodulin, and plasminogen activator ingibitor-1 levels in patients with essential hypertension. Cardiovasc Drugs Ther. 1998;12:463\u20137.","DOI":"10.1023\/A:1007702132210"},{"key":"7235_CR14","unstructured":"Waters J, et al. Use of moxonidine as unitial therapy and in combination in the treatment of essential hypertension: results of the TOPIC (trial of Physiotens in combination) study. J Clin Basic Cardiol. 1999;2:219\u201324."},{"key":"7235_CR15","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/sj.jhh.1001676","volume":"18","author":"AM Sharma","year":"2004","unstructured":"Sharma AM, Wagner T, Marsalek P. Moxonidine in the treatment of overweight and obese patients with the metabolic syndrome: a postmarketing surveillance study. J Hum Hypertens. 2004;18:669\u201375.","journal-title":"J Hum Hypertens"},{"key":"7235_CR16","doi-asserted-by":"crossref","unstructured":"Podzolkov V, et al. Moxonidine in combined therapy of metabolic syndrome. Arte Hypertens. 2008;https:\/\/doi.org\/10.18705\/1607-419X-2007-13-4-246-249.","DOI":"10.18705\/1607-419X-2007-13-4-246-249"},{"key":"7235_CR17","first-page":"S26","volume":"20","author":"A Rapelli","year":"2002","unstructured":"Rapelli A. Hypertension and obesity in menopause. J Hypertens. 2002;20:S26\u20138.","journal-title":"J Hypertens"},{"key":"7235_CR18","doi-asserted-by":"crossref","unstructured":"Eruslanova K, Dudinskaya E, Bazaeva E, Tkacheva O. The positive effect of moxonidine on telomerase activity. J Hypertens. Ovid Technologies (Wolters Kluwer Health); 2021;39:e95. Available from: https:\/\/journals.lww.com\/10.1097\/01.hjh.0000745348.75502.24","DOI":"10.1097\/01.hjh.0000745348.75502.24"},{"key":"7235_CR19","doi-asserted-by":"crossref","unstructured":"Channaraya V, Marya RK, Somasundaram M, Mitra D, Tibrewala KD. Efficacy and tolerability of a \u03b2-1 selective \u03b2 blocker, bisoprolol, as a first-line antihypertensive in Indian patients diagnosed with essential hypertension (BRIGHT): an open-label, multicentric observational study. BMJ Open. 2012;2(3):e000683.","DOI":"10.1136\/bmjopen-2011-000683"},{"key":"7235_CR20","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.jcrc.2005.04.005","volume":"20","author":"GS Doig","year":"2005","unstructured":"Doig GS, Simpson F. Randomization and allocation concealment: a practical guide for researchers. J Crit Care. 2005;20:187\u201391.","journal-title":"J Crit Care"},{"key":"7235_CR21","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC\/ESH guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur Heart J. 2018;39:3021\u2013104.","journal-title":"Eur Heart J"},{"key":"7235_CR22","doi-asserted-by":"publisher","first-page":"36","DOI":"10.18087\/cardio.2508","volume":"S7","author":"E Dudinskaya","year":"2018","unstructured":"Dudinskaya E, Tkacheva O, Bazaeva E. Etc. new opportunities of using moxonidin for control of blood pressure in patients with osteoporosis. Kardiologia. 2018;S7:36\u201345.","journal-title":"Kardiologia"},{"key":"7235_CR23","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1126\/science.7605428","volume":"266","author":"NW Kim","year":"1994","unstructured":"Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, et al. Specific association of human telomerase activity with immortal cells and cancer. Science. 1994;266:2011\u20135.","journal-title":"Science"},{"key":"7235_CR24","doi-asserted-by":"crossref","unstructured":"Van Bortel LM, Laurent S, Boutouyrie P, Chowienczyk P, Cruickshank JK, De Backer T, et al. Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens. 2012;30:445\u20138.","DOI":"10.1097\/HJH.0b013e32834fa8b0"},{"key":"7235_CR25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1161\/HYPERTENSIONAHA.109.129114","volume":"54","author":"P Nilsson","year":"2009","unstructured":"Nilsson P, et al. Vascular aging: a tale of EVA and ADAM in cardiovascular risk assessment and prevention. Hypertension. 2009;54:3\u201310.","journal-title":"Hypertension"},{"key":"7235_CR26","doi-asserted-by":"crossref","unstructured":"Jockel-Schneider Y, Harks I, Haubitz I, Fickl S, Eigenthaler M, Schlagenhauf U, et al. Arterial stiffness and pulse wave reflection are increased in patients suffering from severe periodontitis. PLoS One. Public Libr Sci; 2014;9:e103449.","DOI":"10.1371\/journal.pone.0103449"},{"key":"7235_CR27","doi-asserted-by":"crossref","unstructured":"Engelen L, Ferreira I, Stehouwer CD, Boutouyrie P, Laurent S. Reference intervals for common carotid intima-media thickness measured with echotracking: relation with risk factors. Eur Heart J. 2013 ;34:2368\u201380. https:\/\/academic.oup.com\/eurheartj\/article\/34\/30\/2368\/486500","DOI":"10.1093\/eurheartj\/ehs380"},{"key":"7235_CR28","doi-asserted-by":"crossref","unstructured":"Jarauta E, Mateo-Gallego R, Bea A, Burillo E, Calmarza P, Civeira F. Carotid Intima-Media Thickness in Subjects With No Cardiovascular Risk Factors. Rev Espa\u00f1ola Cardiol (English Ed [Internet]. Elsevier BV; 2010 [cited 2021 Apr 30];63:97\u2013102. http:\/\/www.revespcardiol.org\/en-carotid-intima-media-thickness-in-subjects-articulo-13146858","DOI":"10.1016\/S1885-5857(10)70014-1"},{"key":"7235_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/JCI92035","volume":"127","author":"AR Saltiel","year":"2017","unstructured":"Saltiel AR, Olefsky JM. Inflammatory mechanisms linking obesity and metabolic disease. J Clin Invest Am Soc Clin Invest. 2017;127:1\u20134.","journal-title":"J Clin Invest Am Soc Clin Invest"},{"key":"7235_CR30","doi-asserted-by":"crossref","unstructured":"Webb DR, Khunti K, Silverman R, Gray LJ, Srinivasan B, Lacy PS, et al. Impact of metabolic indices on central artery stiffness: independent association of insulin resistance and glucose with aortic pulse wave velocity. Diabetologia. 2010;53:1190\u20138.","DOI":"10.1007\/s00125-010-1689-9"},{"key":"7235_CR31","first-page":"32","volume":"3","author":"J Friedman","year":"1998","unstructured":"Friedman J, Ishizuka T, Liu S, Farrell C, Koletsky R, Bedol D, et al. Anti-hyperglycemic activity of moxonidine: metabolic and molecular effects in obese spontaneously hypertensive rats. Blood Press Suppl. 1998;3:32\u20139.","journal-title":"Blood Press Suppl"},{"key":"7235_CR32","doi-asserted-by":"crossref","unstructured":"Ernsberger P, Friedman J, Koletsky R. The I1-imidazoline receptor: from binding site to therapeutic target in cardiovascular disease. J Hypertens Suppl.1997;15:S9\u201323. Available from: \/pmc\/articles\/PMC1351308\/.","DOI":"10.1097\/00004872-199715011-00002"},{"key":"7235_CR33","doi-asserted-by":"crossref","unstructured":"Ebin\u00e7 H, Ozkurt ZN, Ebin\u00e7 FA, Ucardag D, Caglayan O, Yilmaz M. Effects of sympatholytic therapy with moxonidine on serum adiponectin levels in hypertensive women. J Int Med Res [Internet]. Cambridge Medical Publications; 2008 [cited 2021 May 4];36:80\u20137. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/18230271\/","DOI":"10.1177\/147323000803600111"},{"key":"7235_CR34","doi-asserted-by":"crossref","unstructured":"Chazova I, Almazov VA, Shlyakhto E. Moxonidine improves glycaemic control in mildly hypertensive, overweight patients: a comparison with metformin. Diabetes, Obes Metab. 2006;8:456\u201365. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/16776753\/","DOI":"10.1111\/j.1463-1326.2006.00606.x"},{"key":"7235_CR35","doi-asserted-by":"crossref","unstructured":"Fyhrquist F, Saijonmaa O, Strandberg T. The roles of senescence and telomere shortening in cardiovascular disease. Nat Rev Cardiol. 2013;10:274\u201383.","DOI":"10.1038\/nrcardio.2013.30"},{"key":"7235_CR36","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.diff.2018.01.003","volume":"100","author":"E Aix","year":"2018","unstructured":"Aix E, Gallinat A, Flores I. Telomeres and telomerase in heart regeneration. Differentiation. 2018;100:26\u201330.","journal-title":"Differentiation."},{"key":"7235_CR37","first-page":"575","volume":"94","author":"AL Serrano","year":"2004","unstructured":"Serrano AL, Andr\u00e9s V. Telomeres and cardiovascular disease. Circ Res Am Heart Association. 2004;94:575\u201384.","journal-title":"Circ Res Am Heart Association"},{"key":"7235_CR38","first-page":"156","volume":"99","author":"C Matthews","year":"2006","unstructured":"Matthews C, Gorenne I, Scott S, Figg N, Kirkpatrick P, Ritchie A, et al. Vascular smooth muscle cells undergo telomere-based senescence in human atherosclerosis. Circ Res. Am Heart Association. 2006;99:156\u201364.","journal-title":"Circ Res. Am Heart Association"},{"key":"7235_CR39","first-page":"255","volume":"4","author":"F Xin","year":"2011","unstructured":"Xin F, Lining W, Yao L. Change of telomere length in angiotensin ii-induced human glomerular mesangial cell senescence and the protective role of losartan. Mol Med Rep. 2011;4:255\u201360.","journal-title":"Mol Med Rep"},{"key":"7235_CR40","doi-asserted-by":"crossref","unstructured":"Le Brigand L, Virsolvy A, Peyrollier K, Manechez D, Godfroid JJ, Guardiola-Lema\u00eetre B, et al. Stimulation of insulin release from the MIN6 cell line by a new imidazoline compound, S-21663: evidence for the existence of a novel imidazoline site in \u03b2 cells. Br J Pharmacol. 1997;122:786\u201391. https:\/\/doi.org\/10.1038\/sj.bjp.0701449.","DOI":"10.1038\/sj.bjp.0701449"},{"key":"7235_CR41","doi-asserted-by":"crossref","unstructured":"Efanov AM, Zaitsev SV, Mest HJ, Raap A, Appelskog IB, Larsson O, et al. The novel imidazoline compound BL11282 potentiates glucose-induced insulin secretion in pancreatic \u03b2-cells in the absence of modulation of KATP channel activity. Diabetes. 2001;50:797\u2013802. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/11289044\/","DOI":"10.2337\/diabetes.50.4.797"},{"key":"7235_CR42","doi-asserted-by":"crossref","unstructured":"Olsen HL, N\u00f8rby PL, H\u00f8y M, Spee P, Thams P, Capito K, et al. Imidazoline NNC77\u20130074 stimulates Ca2+\u2212evoked exocytosis in INS-1E cells by a phospholipase A2-dependent mechanism. Biochem Biophys Res Commun. 2003;303:1148\u201351. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/12684056\/","DOI":"10.1016\/S0006-291X(03)00505-9"},{"key":"7235_CR43","doi-asserted-by":"crossref","unstructured":"Prichard BNC, Graham BR. I1 imidazoline agonists. General clinical pharmacology of imidazoline receptors. Implications for the treatment of the elderly. Drugs Aging. 2000;17:133\u201359. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/10984201\/","DOI":"10.2165\/00002512-200017020-00005"},{"key":"7235_CR44","doi-asserted-by":"crossref","unstructured":"Tesfai J, Crane, L, Mouysset GB. Novel I1-Imidazoline agonist S43126 augment insulin secretion in Min6 cells. J Diabetes Metab. 2012;3:183.","DOI":"10.4172\/2155-6156.1000183"},{"key":"7235_CR45","doi-asserted-by":"crossref","unstructured":"Valdes AM, Andrew T, Gardner JP, Kimura M, Oelsner E, Cherkas LF, et al. Obesity, cigarette smoking, and telomere length in women. Lancet. 2005;366:662\u20134. https:\/\/pubmed.ncbi.nlm.nih.gov\/16112303\/","DOI":"10.1016\/S0140-6736(05)66630-5"},{"key":"7235_CR46","doi-asserted-by":"crossref","unstructured":"Coluzzi E, Leone S, Sgura A. Oxidative stress induces telomere dysfunction and senescence by replication fork arrest. Cells. 2019;8:19. https:\/\/doi.org\/10.3390\/cells8010019.","DOI":"10.3390\/cells8010019"},{"key":"7235_CR47","doi-asserted-by":"crossref","unstructured":"Mangge H, Herrmann M, Almer G, Zelzer S, Moeller R, Horejsi R, et al. Telomere shortening associates with elevated insulin and nuchal fat accumulation. Sci Rep. 2020;10:1\u20139.","DOI":"10.1038\/s41598-020-63916-6"},{"key":"7235_CR48","doi-asserted-by":"crossref","unstructured":"De Zegher F, D\u00edaz M, Ib\u00e1\u00f1ez L. Association between long telomere length and insulin sensitization in adolescent girls with hyperinsulinemic androgen excess. JAMA Pediatr. 2015;169:787\u20138. https:\/\/jamanetwork.com\/","DOI":"10.1001\/jamapediatrics.2015.0439"},{"key":"7235_CR49","doi-asserted-by":"crossref","unstructured":"Jose SS, Bendickova K, Kepak T, Krenova Z, Fric J. Chronic inflammation in immune aging: Role of pattern recognition receptor crosstalk with the telomere complex?. Front Immunol. 2017;8:1078.","DOI":"10.3389\/fimmu.2017.01078"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-021-07235-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10557-021-07235-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-021-07235-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T06:09:31Z","timestamp":1668146971000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10557-021-07235-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,15]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["7235"],"URL":"https:\/\/doi.org\/10.1007\/s10557-021-07235-6","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,15]]},"assertion":[{"value":"29 July 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. The study protocol was approved by the independent ethical committee of the Federal State Budget-Funded Scientific Institution \u201cNIICM\u201d of the Ministry of Health of the Russian Federation (meeting minute\u2019s No. 03\u201306 \/ 15 of 04\/02\/2015).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The study was performed in accordance with the GCP standards and the principles of the Helsinki Declaration. Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All patients signed written informed consent for publication.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}